FDA approves ImmunityBio's Anktiva for BCG-unresponsive non-muscle invasive bladder cancer

The FDA has approved ImmunityBio's Anktiva to treat adults with Bacillus Calmette-Guerin unresponsive non-muscle invasive bladder cancer.

Detected & updated continuously · Source: Nebula